5:33 PM
 | 
Jun 03, 2009
 |  BC Extra  |  Clinical News

Data for TMC207 for MDR-TB published

Data from 47 newly diagnosed multi-drug resistant tuberculosis (MDR-TB) patients in the South African first stage of an ongoing, double-blind Phase II trial showed that TMC207 significantly...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >